Global Circulating Tumor Cell Diagnostics Sales Market Size Growing at a CAGR of 9.2% during 2018-2025

Posted on 2018-06-28 by Mark Hub in Pharmaceuticals // 0 Comments

Market Research HUB

Albany, US, June 28, 2018:A newly compiled business intelligent report, titled “Global Circulating Tumor Cell Diagnostics Sales Market” Report 2018 has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of Circulating Tumor Cell Diagnostics market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360 view on current and future market prospects. As the report proceeds, information regarding the prominent trends as well as opportunities in the key geographical segments have also been explained, thus enabling companies to be able to make region-specific strategies for gaining competitive lead.

Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1843217

This report studies the global Circulating Tumor Cell Diagnostics market status and forecast, categorizes the global Circulating Tumor Cell Diagnostics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.

Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients. It includes enrichment, detection and analysis of the detected circulating tumor cells. Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancer

Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.

On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics. The level of adoption of companion diagnostics is expected to significantly increase after these obtain complete FDA approval and are commercialized fully.
The global Circulating Tumor Cell Diagnostics market is valued at 4990 million US$ in 2017 and will reach 10100 million US$ by the end of 2025, growing at a CAGR of 9.2% during 2018-2025.

The major players covered in this report
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
CTC Enrichment
CTC Detection
CTC Analysis
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-circulating-tumor-cell-diagnostics-sales-market-report-2018-report.html

Table of Contents

Global Circulating Tumor Cell Diagnostics Sales Market Report 2018
1 Circulating Tumor Cell Diagnostics Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell Diagnostics
1.2 Classification of Circulating Tumor Cell Diagnostics by Product Category
1.2.1 Global Circulating Tumor Cell Diagnostics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Circulating Tumor Cell Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cell Diagnostics Market by Application/End Users
1.3.1 Global Circulating Tumor Cell Diagnostics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Tumorigenesis research
1.3.2 EMT biomarkers development
1.3.3 Cancer stem cell research
1.3.4 Others
1.4 Global Circulating Tumor Cell Diagnostics Market by Region
1.4.1 Global Circulating Tumor Cell Diagnostics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.4.3 Europe Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.4.4 China Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.4.5 Japan Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.4.7 India Circulating Tumor Cell Diagnostics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Circulating Tumor Cell Diagnostics (2013-2025)
1.5.1 Global Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2025)
1.5.2 Global Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2025)

2 Global Circulating Tumor Cell Diagnostics Competition by Players/Suppliers, Type and Application
2.1 Global Circulating Tumor Cell Diagnostics Market Competition by Players/Suppliers
2.1.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Circulating Tumor Cell Diagnostics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Circulating Tumor Cell Diagnostics (Volume and Value) by Type
2.2.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share by Type (2013-2018)
2.2.2 Global Circulating Tumor Cell Diagnostics Revenue and Market Share by Type (2013-2018)
2.3 Global Circulating Tumor Cell Diagnostics (Volume and Value) by Region
2.3.1 Global Circulating Tumor Cell Diagnostics Sales and Market Share by Region (2013-2018)
2.3.2 Global Circulating Tumor Cell Diagnostics Revenue and Market Share by Region (2013-2018)
2.4 Global Circulating Tumor Cell Diagnostics (Volume) by Application

3 United States Circulating Tumor Cell Diagnostics (Volume, Value and Sales Price)
3.1 United States Circulating Tumor Cell Diagnostics Sales and Value (2013-2018)
3.1.1 United States Circulating Tumor Cell Diagnostics Sales and Growth Rate (2013-2018)
3.1.2 United States Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2013-2018)
3.1.3 United States Circulating Tumor Cell Diagnostics Sales Price Trend (2013-2018)
3.2 United States Circulating Tumor Cell Diagnostics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Circulating Tumor Cell Diagnostics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Circulating Tumor Cell Diagnostics Sales Volume and Market Share by Application (2013-2018)

Continued… @@

Enquire about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1843217

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick